Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Conatus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Conatus Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Conatus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Conatus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Conatus Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
Conatus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Conatus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
IDUN Pharma Raises USD1.1 Million in Financing 12
IDUN Pharma Raises Additional USD0.2 Million in Financing 13
Idun Pharma Raises USD0.23 Millin in Extended Venture Financing 14
Idun Pharma Raises US$0.3 Million In Venture Financing 15
Partnerships 16
Conatus Pharma Enters into Co-Development Agreement with Novartis Pharma 16
Licensing Agreements 18
Novartis Pharma Exercises Option for Licensing Agreement with Conatus Pharma 18
Conatus Pharma Enters into Sub-Licensing Agreement with Idun Pharma 19
Equity Offering 20
Conatus Pharma to Raise up to USD35 Million in Public Offering of Shares 20
Conatus Pharma Raises USD32.89 Million in Public Offering of Shares 21
Conatus Pharma Raises USD23 Million in Public Offering of Shares 23
Conatus Pharmaceuticals Completes IPO Of Shares For US$66 Million 25
Debt Offering 27
Conatus Pharmaceuticals Raises USD1 Million in Private Placement of Notes 27
Conatus Pharmaceuticals Inc – Key Competitors 28
Conatus Pharmaceuticals Inc – Key Employees 29
Conatus Pharmaceuticals Inc – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Financial Announcements 31
Aug 01, 2018: Conatus Pharmaceuticals Reports Second Quarter 2018 Financial Results and Program Updates 31
May 02, 2018: Conatus Pharmaceuticals Reports First Quarter 2018 Financial Results and Program Updates 33
Mar 07, 2018: Conatus Pharmaceuticals Reports 2017 Financial Results and Program Updates 34
Nov 01, 2017: Conatus Pharmaceuticals Reports Third Quarter 2017 Financial Results and Program Updates 36
Aug 02, 2017: Conatus Pharmaceuticals Reports Second Quarter 2017 Financial Results and Program Updates 38
May 04, 2017: Conatus Pharmaceuticals Reports First Quarter 2017 Financial Results and Program Updates 40
Mar 15, 2017: Conatus Pharmaceuticals Reports 2016 Financial Results and Program Updates 41
Corporate Communications 43
Aug 31, 2017: Conatus Pharmaceuticals Appoints Keith W. Marshall as Executive Vice President, Chief Operating Officer and Chief Financial Officer 43
Feb 07, 2017: Conatus Pharmaceuticals Appoints William R. LaRue as Independent Board Member 44
Feb 02, 2017: Conatus Pharmaceuticals Promotes Daniel L. Ripley to Senior Vice President, Business Development, Program and Alliance Management 45
Product Approvals 46
Jun 26, 2017: FDA Grants Conatus Orphan Drug Designation for IDN-7314 for the Treatment of PSC 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47
Conatus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Conatus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Conatus Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Conatus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Conatus Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Conatus Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
Conatus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
IDUN Pharma Raises USD1.1 Million in Financing 12
IDUN Pharma Raises Additional USD0.2 Million in Financing 13
Idun Pharma Raises USD0.23 Millin in Extended Venture Financing 14
Idun Pharma Raises US$0.3 Million In Venture Financing 15
Conatus Pharma Enters into Co-Development Agreement with Novartis Pharma 16
Novartis Pharma Exercises Option for Licensing Agreement with Conatus Pharma 18
Conatus Pharma Enters into Sub-Licensing Agreement with Idun Pharma 19
Conatus Pharma to Raise up to USD35 Million in Public Offering of Shares 20
Conatus Pharma Raises USD32.89 Million in Public Offering of Shares 21
Conatus Pharma Raises USD23 Million in Public Offering of Shares 23
Conatus Pharmaceuticals Completes IPO Of Shares For US$66 Million 25
Conatus Pharmaceuticals Raises USD1 Million in Private Placement of Notes 27
Conatus Pharmaceuticals Inc, Key Competitors 28
Conatus Pharmaceuticals Inc, Key Employees 29
Conatus Pharmaceuticals Inc, Subsidiaries 30
List of Figures
Conatus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Conatus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Conatus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Conatus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Conatus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Conatus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Conatus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Conatus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Conatus Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10